Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

NCT02559778 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Ceritinib
DRUG: dasatinib
DRUG: sorafenib
DRUG: vorinostat
DRUG: DFMO

Sponsor

Giselle Sholler

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]